title: Facial hyperpigmentation during pegylated interferon alpha therapy for chronic hepatitis B infection.
authors.forename: M S
authors.initials: MS
authors.lastname: Dag
authors.forename: M
authors.initials: M
authors.lastname: Aydinli
authors.forename: U
authors.initials: U
authors.lastname: Kazanci
authors.forename: A
authors.initials: A
authors.lastname: Kadayifci
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D005148:Facial Dermatoses / Q000139:chemically induced*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins